drugset
drugset / Trial / NCT04461886

A Long-term Study of NPC-12G Gel in Neurofibromatosis Type I

NCT04461886 ↗

Phase 3 Terminated 100 enrolled Nobelpharma
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this tria is to evaluate the safety and efficacy of long-term treatment with NPC-12G gel to patients with neurofibromatosis type I.

Timeline

Start
2020-07-08
Primary completion
2021-12-07
Completion
2021-12-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Sirolimus Small molecule 0.2 % —

Indications

neurofibromatosis